Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2025-12-24 @ 11:53 PM
NCT ID:
NCT01881451
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed, advanced metastatic or recurrent clear cell cancer of the ovary
* At least one index lesion measuring 2 cm in diameter
* Must be able to provide written informed consent, and willing to comply with protocol procedures of the study
* Off all active therapy for at least 4 weeks (cytotoxic chemotherapy, radiation, immune therapy, hormone therapy, clinical trials or new agents)
Exclusion Criteria:
* Renal failure (eGFR \< 50mls/min)
* Patients with unknown primaries
* Previous history of cancer, except treated non-melanoma skin cancer, non-invasive breast cancer, non-invasive cervical cancer; or curatively treated solid cancer with no evidence of recurrence for more than 5 years.
* Receiving or had received active therapy in the form or chemotherapy or radiation within 4 weeks of the PET scan
* ECOG status ≥ 3
* Unable to tolerate a PET scan which involves an injection of radiopharmaceutical and lying flat and still for 30 minutes.
* Weight more than 204.5 kg (Physical Limitation of Imaging and Radiotherapy Couches) or cannot fit through the PET/CT machine (diameter 70cm).
* Patient is pregnant or breastfeeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT01881451
Study Brief:
Protocol Section:
NCT01881451